Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group.
暂无分享,去创建一个
[1] J. Copeland,et al. Selection of patients for cardiac transplantation. , 1987, Circulation.
[2] B. Griffith,et al. Prostaglandin E1: an effective treatment of right heart failure after orthotopic heart transplantation. , 1987, The Journal of heart transplantation.
[3] L. Cohn,et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. , 1987, Circulation.
[4] J. Schroeder,et al. Hemodynamic Observations One and Two Years after Cardiac Transplantation in Man , 1972, Circulation.
[5] E. Stinson,et al. Determinants of operative risk in human heart transplantation. , 1971, American journal of surgery.
[6] B. Firth,et al. Independence of oxygen consumption and systemic oxygen transport in patients with either stable pulmonary hypertension or refractory left ventricular failure. , 2015, The American review of respiratory disease.
[7] J. Shaver,et al. Hemodynamic observations after cardiac transplantation. , 1969, The New England journal of medicine.
[8] E. Knapp,et al. Reduction of pulmonary hypertension by nitroprusside. , 1977, International journal of clinical pharmacology and biopharmacy.
[9] W. Baumgartner,et al. Acute right ventricular failure following heart transplantation: improvement with prostaglandin E1 and right ventricular assist. , 1986, The Journal of heart transplantation.
[10] D. Behrendt,et al. Potential for reversibility of pulmonary vascular obstructive disease in children after cardiac transplantation. , 1986, The American journal of cardiology.
[11] V. Gott,et al. Reversal of experimental pulmonary hypertension with sodium nitroprusside. , 1981, The Journal of thoracic and cardiovascular surgery.
[12] E. Blackstone,et al. Analysis of morbid events and risk factors for death after cardiac transplantation. , 1988, Journal of the American College of Cardiology.
[13] S. Jamieson,et al. Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. , 1982, The Journal of thoracic and cardiovascular surgery.
[14] G. Lepage,et al. Cardiac catheterization findings at rest and after exercise in patients following cardiac transplantation. , 1970, The American journal of cardiology.
[15] S. Bolling,et al. Prolonged amrinone therapy prior to orthotopic cardiac transplantation in patients with pulmonary hypertension. , 1988, Transplantation proceedings.
[16] E. Blackstone,et al. Pulmonary vascular resistance and the risk of heart transplantation. , 1988, The Journal of heart transplantation.